tiprankstipranks
Lexeo Therapeutics, Inc. (LXEO)
NASDAQ:LXEO
US Market

Lexeo Therapeutics, Inc. (LXEO) Technical Analysis

73 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
6Neutral
3Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
8Bullish
0Neutral
2Bearish
Lexeo Therapeutics, Inc.’s (LXEO) Moving Averages Convergence Divergence (MACD) indicator is 0.17, suggesting Lexeo Therapeutics, Inc. is a Sell.
Lexeo Therapeutics, Inc.’s (LXEO) 20-Day exponential moving average is 13.40, while Lexeo Therapeutics, Inc.’s (LXEO) share price is $13.85, making it a Buy.
Lexeo Therapeutics, Inc.’s (LXEO) 50-Day exponential moving average is 13.62, while Lexeo Therapeutics, Inc.’s (LXEO) share price is $13.85, making it a Buy.

Lexeo Therapeutics, Inc. (LXEO) Pivot Points

May 20, 2024, 04:04 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
12.18
13.00
13.51
14.33
14.84
15.66
16.17
Fibonacci
13.00
13.51
13.82
14.33
14.84
15.15
15.66
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Lexeo Therapeutics, Inc. (LXEO) Moving Averages

May 20, 2024, 04:04 AM
Period
Simple
Exponential
MA5
13.87Sell
13.85Buy
MA10
13.74Buy
13.64Buy
MA20
13.08Buy
13.40Buy
MA50
13.72Buy
13.62Buy
MA100
14.71Sell
13.75Buy
Lexeo Therapeutics, Inc.’s (LXEO) 10-Day exponential moving average is 13.64, while Lexeo Therapeutics, Inc.’s (LXEO) share price is $13.85, making it a Buy.
Lexeo Therapeutics, Inc.’s (LXEO) 100-Day exponential moving average is 13.75, while Lexeo Therapeutics, Inc.’s (LXEO) share price is $13.85, making it a Buy.
Lexeo Therapeutics, Inc.’s (LXEO) stock price is $13.85 and Lexeo Therapeutics, Inc.’s (LXEO) 50-day simple moving average is 13.72, creating a Buy signal.
Lexeo Therapeutics, Inc.’s (LXEO) stock price is $13.85 and Lexeo Therapeutics, Inc.’s (LXEO) 100-day simple moving average is 14.71, creating a Sell signal.

Lexeo Therapeutics, Inc. (LXEO) Technical Indicators

May 20, 2024, 04:04 AM
Name
Value
Implied Action
RSI (14)
54.73
Neutral
STOCH (9,6)
28.68
Neutral
STOCHRSI (14)
40.06
Neutral
MACD (12,26)
0.17
Sell
ADX (14)
30.82
Neutral
Williams %R
-63.09
Buy
CCI (14)
76.80
Neutral
ATR (14)
1.03
-
Ultimate Oscillator
32.76
Neutral
ROC
12.60
Buy
Lexeo Therapeutics, Inc.’s (LXEO) Relative Strength Index (RSI) is 54.73, creating a Neutral signal.
Lexeo Therapeutics, Inc.’s (LXEO) Trend Strength Indicator (ADX) is 30.82, creating a Neutral signal.
Lexeo Therapeutics, Inc.’s (LXEO) Commodity Channel Index (CCI) is 76.80, creating a Neutral signal.
Lexeo Therapeutics, Inc.’s (LXEO) Price Rate of Change (ROC) is 12.60, creating a Buy signal.

FAQ

Is LXEO a Buy, Hold, or Sell?
Based on LXEO’s technical indicators, LXEO is a Buy.
    What is LXEO’s RSI (14)?
    LXEO’s RSI (14) is 54.73, which suggests LXEO is a Neutral.
      What is LXEO’s MACD?
      LXEO’s MACD is 0.17, which suggests LXEO is a Sell.
        What is LXEO’s 5-day moving average?
        LXEO’s 5-day moving average is 13.87, which suggests LXEO is a Sell.
          What is LXEO’s 20-day moving average?
          LXEO 20-day moving average is 13.08, which suggests LXEO is a Buy.
            What is LXEO’s 50-day moving average?
            LXEO’s 50-day moving average is 13.72, which suggests LXEO is a Buy.
              What is LXEO’s 200-day moving average?
              Currently, no data Available
              What is LXEO’s Williams % R (14)?
              LXEO’s Williams % R (14) is -63.09, which suggests LXEO is a Buy.
                What is LXEO’s CCI (14)?
                LXEO’s CCI (14) is 76.80, which suggests LXEO is a Neutral.
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis